Solventum Corporation (solv)
SOLV Financials
| Trailing P/E | 10.80 |
| Forward P/E | 12.22 |
| Price/Sales | 1.81 |
| Price/Book | 3.13 |
| Market cap | $15.04B |
| Avg volume | 1103959.0 |
| Shares outstanding | 170223729.0 |
Start Free — open SOLV in Vest Terminal
Access live data, filings, ownership, and analysis for Solventum Corporation.
Solventum Corporation FAQ
What does Solventum Corporation (SOLV) do?
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Inf…
What is SOLV's P/E ratio?
Solventum Corporation has a trailing P/E of 10.80× based on publicly available market data.
Does SOLV pay a dividend?
Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.
What sector is SOLV in?
Solventum Corporation is classified in Healthcare (Medical Instruments & Supplies) on NYQ.
What is SOLV's market capitalization?
Approximate market cap: $15.04B.
What are the main risks for SOLV?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of SOLV?
Potential positives include earnings growth of 3.9% year-over-year, return on equity near 34.0% — efficient use of shareholder capital.
Where can I get analyst estimates for SOLV?
Public analyst price targets and consensus for Solventum Corporation are on the free /stocks/solv/estimates page. Deeper estimate history and models are available in Vest Terminal.